Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Intangibles (2016 - 2025)

Conmed (CNMD) has disclosed Intangibles for 16 consecutive years, with $593.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Intangibles fell 5.19% year-over-year to $593.1 million, compared with a TTM value of $593.1 million through Sep 2025, down 5.19%, and an annual FY2024 reading of $617.7 million, down 4.9% over the prior year.
  • Intangibles was $593.1 million for Q3 2025 at Conmed, down from $601.8 million in the prior quarter.
  • Across five years, Intangibles topped out at $689.5 million in Q3 2022 and bottomed at $471.0 million in Q4 2021.
  • Average Intangibles over 5 years is $606.4 million, with a median of $625.6 million recorded in 2024.
  • The sharpest move saw Intangibles fell 6.08% in 2021, then soared 44.74% in 2022.
  • Year by year, Intangibles stood at $471.0 million in 2021, then surged by 44.74% to $681.8 million in 2022, then fell by 4.74% to $649.5 million in 2023, then fell by 4.9% to $617.7 million in 2024, then fell by 3.98% to $593.1 million in 2025.
  • Business Quant data shows Intangibles for CNMD at $593.1 million in Q3 2025, $601.8 million in Q2 2025, and $617.7 million in Q4 2024.